<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Five consecutive patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were treated with antithymocyte globulin followed by <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> received antithymocyte globulin initially, and because of lack of response within a 4 week period, cyclosporin was administered subsequently </plain></SENT>
<SENT sid="2" pm="."><plain>Hematologic improvement occurred within four months of initiation of cyclosporin </plain></SENT>
<SENT sid="3" pm="."><plain>Four patients no longer require blood product support, while one remains transfusion-dependent </plain></SENT>
<SENT sid="4" pm="."><plain>In two patients, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> developed when the cyclosporin was tapered but re-institution of the drug resulted in a prompt improvement of counts </plain></SENT>
<SENT sid="5" pm="."><plain>These observations indicate that the sequential use of antithymocyte globulin and cyclosporin may be an effective therapeutic approach in the treatment of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>